AFX Carl Zeiss Meditec AG

DGAP-News: Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

DGAP-News: Carl Zeiss Meditec AG / Key word(s): AGM/EGM
Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

17.03.2020 / 10:38
The issuer is solely responsible for the content of this announcement.

Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events
 
 

JENA, 17 March 2020

On the basis of the decree of the President of the State Administration Office of Thuringia (Landesverwaltungsamt Thüringen) of 14 March 2020, according to which "events and meetings of people with 50 or more persons must be prohibited from now until further notice", the Management Board of Carl Zeiss Meditec AG has decided to postpone the Annual General Meeting, which was scheduled for Tuesday, 24 March 2020 (published in the Federal Gazette (Bundesanzeiger) of 11 February 2020); it will therefore not take place. A new date will be announced in time.

 

Contact for investors and press

Sebastian Frericks
Director Investor Relations, Carl Zeiss Meditec AG
Tel. 03641 220-116
E-Mail:


17.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail:
Internet: /meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 999125

 
End of News DGAP News Service

999125  17.03.2020 

fncls.ssp?fn=show_t_gif&application_id=999125&application_name=news&site_id=research_pool
EN
17/03/2020

Underlying

AFXCarl Zeiss Meditec AG

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Carl Zeiss Meditec AG

Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
AFX Carl Zeiss Medi...

Dr. Markus Weber (CEO) surprisingly leaves the company - internal solu...

Surprisingly, Dr. Markus Weber, who has been CEO since 01.01.22, will hand over his office to Maximilian Foerst, who has been with ZEISS since 1995 and is currently Head of ZEISS Greater China, on 31.05.25. The handover will take place at Dr. Weber's own request and "in the best agreement with the Supervisory Board". In our opinion, greater attention will be paid to sales in the future, which will support the upcoming product launches and thus secure the targeted topline impulse. CFO Justus Feli...

AFX CARL ZEISS MEDITEC AG
05/08/25 May 8, 2025 4 EN
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
AFX Carl Zeiss Medi...

Dr. Markus Weber (CEO) verlässt überraschend das Unternehmen - interne...

Überraschend wird Dr. Markus Weber, der seit 01.01.22 CEO ist, sein Amt zum 31. 05.25 an Maximilian Foerst, seit 1995 bei ZEISS und derzeit Head of ZEISS Greater China, übergeben. Die Übergabe geschieht auf eigenen Wunsch von Dr. Weber und „im besten Einvernehmen mit dem Aufsichtsrat“. U.E. wird dem Vertrieb künftig eine größere Aufmerksamkeit zuteil, was die anstehenden Produkteinführungen unterstützt und so den anvisierten Topline-Impuls absichern soll. Der CFO Justus Felix Wehmer bleibt im Am...

AFX CARL ZEISS MEDITEC AG
05/08/25 May 8, 2025 5 DE
 PRESS RELEASE
Free
AFX Carl Zeiss Medi...

EQS-News: ZEISS VISUMAX 800 with SMILE pro software receives approval ...

EQS-News: Carl Zeiss Meditec AG / Key word(s): Regulatory Approval ZEISS VISUMAX 800 with SMILE pro software receives approval in China 27.02.2025 / 10:38 CET/CEST The issuer is solely responsible for the content of this announcement. ZEISS VISUMAX 800 with SMILE pro software receives approval in China   Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements.   JENA,(Germany), SHANGHAI, (China), | 27 February 2025 | Carl Zeiss Meditec AG ZEISS Medical Technology annou...

February 27, 2025 1 EN
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
AFX Carl Zeiss Medi...

Q1/24-25 erwartet schwach – graduelle Erholung folgt –Produkt-Launches...

Die anhaltende Zurückhaltung der Endverbraucher in China (verstärkt um Spekulationen auf Konjunkturhilfen dort) und Preisdruck bei IO-Linsen trafen im Q1/25 auf negative Produktzyklus-Effekte. Q2/25 werde etwas besser, so der CFO.

AFX CARL ZEISS MEDITEC AG
02/13/25 February 13, 2025 5 DE
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
AFX Carl Zeiss Medi...

Q1/24-25 expected to be weak – gradual recovery to follow – product la...

The ongoing reluctance of end consumers in China (intensified by speculation about economic stimulus there) and price pressure for IO lenses met negative product cycle effects in Q1/25. Q2/25 will be slightly better, according to the CFO.

AFX CARL ZEISS MEDITEC AG
02/13/25 February 13, 2025 4 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch